Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular Degeneration

Macular neovascularization (MNV) and geographic atrophy can complicate age-related macular degeneration (AMD) and lead to severe visual acuity reduction. Despite the medical treatments available, with a defect in the retinal pigmented epithelium (RPE) there is no possibility of restoring acceptable...

Full description

Bibliographic Details
Main Authors: Tomaso Caporossi, Alessandra Scampoli, Antonio Baldascino, Gloria Gambini, Bianca Pacini, Lorenzo Governatori, Daniela Bacherini, Matteo Mario Carlà, Emanuele Crincoli, Clara Rizzo, Raphael Kilian, Stanislao Rizzo
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/12/12/1998
_version_ 1797456722858606592
author Tomaso Caporossi
Alessandra Scampoli
Antonio Baldascino
Gloria Gambini
Bianca Pacini
Lorenzo Governatori
Daniela Bacherini
Matteo Mario Carlà
Emanuele Crincoli
Clara Rizzo
Raphael Kilian
Stanislao Rizzo
author_facet Tomaso Caporossi
Alessandra Scampoli
Antonio Baldascino
Gloria Gambini
Bianca Pacini
Lorenzo Governatori
Daniela Bacherini
Matteo Mario Carlà
Emanuele Crincoli
Clara Rizzo
Raphael Kilian
Stanislao Rizzo
author_sort Tomaso Caporossi
collection DOAJ
description Macular neovascularization (MNV) and geographic atrophy can complicate age-related macular degeneration (AMD) and lead to severe visual acuity reduction. Despite the medical treatments available, with a defect in the retinal pigmented epithelium (RPE) there is no possibility of restoring acceptable visual acuity. We evaluated postoperative outcomes in patients affected by advanced AMD who underwent subretinal implant of the human amniotic membrane (hAM) as a source of pluripotent stem cells. This retrospective, consecutive, non-randomized interventional study included 23 eyes of 21 patients affected by AMD complicated by MNV, and five eyes of five patients affected by geographic atrophy. All eyes underwent a pars plana vitrectomy, neovascular membrane removal for the MNV group, a subretinal implant of hAM, and gas tamponade, and were followed for 12 months. The primary study outcome was visual acuity improvement. Secondary outcomes were postoperative complications, OCT-angiography parameters correlated with best-corrected visual acuity (BCVA) and MNV recurrence. The mean preoperative BCVA was 1.9 logMAR, and the mean final BCVA value was 1.2 logMAR. In the MNV group, the mean BCVA improved from 1.84 logMAR to 1.26 logMAR, and from 1.84 logMAR to 1.32 logMAR in the geographic atrophy group. No MNV recurrence was evident in 12 months of follow-up. An OCT-angiography scan was used to evaluate the retinal vascularization in the treated eye, which showed a high correlation between BCVA and deep vascular density. This study demonstrates the hAM potential and safety in promoting a partial restoration of retinal function together with an increase in visual acuity.
first_indexed 2024-03-09T16:10:57Z
format Article
id doaj.art-5ef02f547dfe4dee8bfa847340f6dcd5
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-09T16:10:57Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-5ef02f547dfe4dee8bfa847340f6dcd52023-11-24T16:11:50ZengMDPI AGLife2075-17292022-11-011212199810.3390/life12121998Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular DegenerationTomaso Caporossi0Alessandra Scampoli1Antonio Baldascino2Gloria Gambini3Bianca Pacini4Lorenzo Governatori5Daniela Bacherini6Matteo Mario Carlà7Emanuele Crincoli8Clara Rizzo9Raphael Kilian10Stanislao Rizzo11Ophthalmology Unit, “Fondazione Policlinico Universitario A. Gemelli IRCCS”, 00168 Rome, ItalyOphthalmology Unit, “Fondazione Policlinico Universitario A. Gemelli IRCCS”, 00168 Rome, ItalyOphthalmology Unit, “Fondazione Policlinico Universitario A. Gemelli IRCCS”, 00168 Rome, ItalyOphthalmology Unit, “Fondazione Policlinico Universitario A. Gemelli IRCCS”, 00168 Rome, ItalyDepartment of NEUROFARBA, Ophthalmology, University of Florence, Careggi, 50139 Florence, ItalyDepartment of NEUROFARBA, Ophthalmology, University of Florence, Careggi, 50139 Florence, ItalyDepartment of NEUROFARBA, Ophthalmology, University of Florence, Careggi, 50139 Florence, ItalyOphthalmology Unit, “Fondazione Policlinico Universitario A. Gemelli IRCCS”, 00168 Rome, ItalyOphthalmology Unit, “Fondazione Policlinico Universitario A. Gemelli IRCCS”, 00168 Rome, ItalyOphthalmology Unit, Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, 56122 Pisa, ItalyOphthalmology Unit, University of Verona, 37129 Verona, ItalyOphthalmology Unit, “Fondazione Policlinico Universitario A. Gemelli IRCCS”, 00168 Rome, ItalyMacular neovascularization (MNV) and geographic atrophy can complicate age-related macular degeneration (AMD) and lead to severe visual acuity reduction. Despite the medical treatments available, with a defect in the retinal pigmented epithelium (RPE) there is no possibility of restoring acceptable visual acuity. We evaluated postoperative outcomes in patients affected by advanced AMD who underwent subretinal implant of the human amniotic membrane (hAM) as a source of pluripotent stem cells. This retrospective, consecutive, non-randomized interventional study included 23 eyes of 21 patients affected by AMD complicated by MNV, and five eyes of five patients affected by geographic atrophy. All eyes underwent a pars plana vitrectomy, neovascular membrane removal for the MNV group, a subretinal implant of hAM, and gas tamponade, and were followed for 12 months. The primary study outcome was visual acuity improvement. Secondary outcomes were postoperative complications, OCT-angiography parameters correlated with best-corrected visual acuity (BCVA) and MNV recurrence. The mean preoperative BCVA was 1.9 logMAR, and the mean final BCVA value was 1.2 logMAR. In the MNV group, the mean BCVA improved from 1.84 logMAR to 1.26 logMAR, and from 1.84 logMAR to 1.32 logMAR in the geographic atrophy group. No MNV recurrence was evident in 12 months of follow-up. An OCT-angiography scan was used to evaluate the retinal vascularization in the treated eye, which showed a high correlation between BCVA and deep vascular density. This study demonstrates the hAM potential and safety in promoting a partial restoration of retinal function together with an increase in visual acuity.https://www.mdpi.com/2075-1729/12/12/1998age-related macular degenerationmacular neovascularizationstem cellsregenerative ophthalmologyhuman amniotic membraneOCT-angiography
spellingShingle Tomaso Caporossi
Alessandra Scampoli
Antonio Baldascino
Gloria Gambini
Bianca Pacini
Lorenzo Governatori
Daniela Bacherini
Matteo Mario Carlà
Emanuele Crincoli
Clara Rizzo
Raphael Kilian
Stanislao Rizzo
Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular Degeneration
Life
age-related macular degeneration
macular neovascularization
stem cells
regenerative ophthalmology
human amniotic membrane
OCT-angiography
title Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular Degeneration
title_full Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular Degeneration
title_fullStr Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular Degeneration
title_full_unstemmed Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular Degeneration
title_short Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular Degeneration
title_sort subretinal transplant of human amniotic membrane in advanced age related macular degeneration
topic age-related macular degeneration
macular neovascularization
stem cells
regenerative ophthalmology
human amniotic membrane
OCT-angiography
url https://www.mdpi.com/2075-1729/12/12/1998
work_keys_str_mv AT tomasocaporossi subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT alessandrascampoli subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT antoniobaldascino subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT gloriagambini subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT biancapacini subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT lorenzogovernatori subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT danielabacherini subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT matteomariocarla subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT emanuelecrincoli subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT clararizzo subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT raphaelkilian subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration
AT stanislaorizzo subretinaltransplantofhumanamnioticmembraneinadvancedagerelatedmaculardegeneration